Global Bio-based Pentylenediamine Market Research Report 2021

1 Bio-based Pentylenediamine Market Overview

• 1.1 Product Overview and Scope of Bio-based Pentylenediamine
• 1.2 Bio-based Pentylenediamine Segment by Type
  • 1.2.1 Global Bio-based Pentylenediamine Market Size Growth Rate Analysis by Type 2021 VS 2027
  • 1.2.2 Polyamide
  • 1.2.3 PDI
  • 1.2.4 Epoxy Curing Agent
  • 1.2.5 Organic Synthesis Intermediate
  • 1.2.6 Others
• 1.3 Bio-based Pentylenediamine Segment by Application
  • 1.3.1 Global Bio-based Pentylenediamine Consumption Comparison by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Spinning
  • 1.3.3 Engineering Materials
  • 1.3.4 Medicine
  • 1.3.5 Pesticides
  • 1.3.6 Organic Synthesis
  • 1.3.7 Others
• 1.4 Global Market Growth Prospects
  • 1.4.1 Global Bio-based Pentylenediamine Revenue Estimates and Forecasts (2016-2027)
  • 1.4.2 Global Bio-based Pentylenediamine Production Capacity Estimates and Forecasts (2016-2027)
  • 1.4.3 Global Bio-based Pentylenediamine Production Estimates and Forecasts (2016-2027)
• 1.5 Global Market Size by Region
  • 1.5.1 Global Bio-based Pentylenediamine Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 2027
  • 1.5.2 North America Bio-based Pentylenediamine Estimates and Forecasts (2016-2027)
  • 1.5.3 Europe Bio-based Pentylenediamine Estimates and Forecasts (2016-2027)
  • 1.5.4 China Bio-based Pentylenediamine Estimates and Forecasts (2016-2027)
  • 1.5.5 Japan Bio-based Pentylenediamine Estimates and Forecasts (2016-2027)

2 Market Competition by Manufacturers

• 2.1 Global Bio-based Pentylenediamine Production Capacity Market Share by Manufacturers (2016-2021)
• 2.2 Global Bio-based Pentylenediamine Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Bio-based Pentylenediamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.4 Global Bio-based Pentylenediamine Average Price by Manufacturers (2016-2021)
• 2.5 Manufacturers Bio-based Pentylenediamine Production Sites, Area Served, Product Types
• 2.6 Bio-based Pentylenediamine Market Competitive Situation and Trends
  • 2.6.1 Bio-based Pentylenediamine Market Concentration Rate
  • 2.6.2 Global 5 and 10 Largest Bio-based Pentylenediamine Players Market Share by Revenue
  • 2.6.3 Mergers & Acquisitions, Expansion

3 Production and Capacity by Region

• 3.1 Global Production Capacity of Bio-based Pentylenediamine Market Share by Region (2016-2021)
• 3.2 Global Bio-based Pentylenediamine Revenue Market Share by Region (2016-2021)
• 3.3 Global Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
• 3.4 North America Bio-based Pentylenediamine Production
  • 3.4.1 North America Bio-based Pentylenediamine Production Growth Rate (2016-2021)
  • 3.4.2 North America Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
• 3.5 Europe Bio-based Pentylenediamine Production
  • 3.5.1 Europe Bio-based Pentylenediamine Production Growth Rate (2016-2021)
  • 3.5.2 Europe Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
• 3.6 China Bio-based Pentylenediamine Production
  • 3.6.1 China Bio-based Pentylenediamine Production Growth Rate (2016-2021)
  • 3.6.2 China Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
• 3.7 Japan Bio-based Pentylenediamine Production
  • 3.7.1 Japan Bio-based Pentylenediamine Production Growth Rate (2016-2021)
  • 3.7.2 Japan Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Bio-based Pentylenediamine Consumption by Region

• 4.1 Global Bio-based Pentylenediamine Consumption by Region
  • 4.1.1 Global Bio-based Pentylenediamine Consumption by Region
  • 4.1.2 Global Bio-based Pentylenediamine Consumption Market Share by Region
• 4.2 North America
  • 4.2.1 North America Bio-based Pentylenediamine Consumption by Country
  • 4.2.2 United States
  • 4.2.3 Canada
• 4.3 Europe
  • 4.3.1 Europe Bio-based Pentylenediamine Consumption by Country
  • 4.3.2 Germany
  • 4.3.3 France
  • 4.3.4 U.K.
  • 4.3.5 Italy
  • 4.3.6 Russia
• 4.4 Asia Pacific
  • 4.4.1 Asia Pacific Bio-based Pentylenediamine Consumption by Region
  • 4.4.2 China
  • 4.4.3 Japan
  • 4.4.4 South Korea
  • 4.4.5 Taiwan
  • 4.4.6 Southeast Asia
  • 4.4.7 India
  • 4.4.8 Australia
• 4.5 Latin America
  • 4.5.1 Latin America Bio-based Pentylenediamine Consumption by Country
  • 4.5.2 Mexico
  • 4.5.3 Brazil

5 Production, Revenue, Price Trend by Type

• 5.1 Global Bio-based Pentylenediamine Production Market Share by Type (2016-2021)
• 5.2 Global Bio-based Pentylenediamine Revenue Market Share by Type (2016-2021)
• 5.3 Global Bio-based Pentylenediamine Price by Type (2016-2021)

6 Consumption Analysis by Application

• 6.1 Global Bio-based Pentylenediamine Consumption Market Share by Application (2016-2021)
• 6.2 Global Bio-based Pentylenediamine Consumption Growth Rate by Application (2016-2021)

7 Key Companies Profiled

• 7.1 Cathay Biotech Inc.
  • 7.1.1 Cathay Biotech Inc. Bio-based Pentylenediamine Corporation Information
  • 7.1.2 Cathay Biotech Inc. Bio-based Pentylenediamine Product Portfolio
  • 7.1.3 Cathay Biotech Inc. Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.1.4 Cathay Biotech Inc. Main Business and Markets Served
  • 7.1.5 Cathay Biotech Inc. Recent Developments/Updates
• 7.2 Aphena Pharma Solutions
  • 7.2.1 Aphena Pharma Solutions Bio-based Pentylenediamine Corporation Information
  • 7.2.2 Aphena Pharma Solutions Bio-based Pentylenediamine Product Portfolio
  • 7.2.3 Aphena Pharma Solutions Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.2.4 Aphena Pharma Solutions Main Business and Markets Served
  • 7.2.5 Aphena Pharma Solutions Recent Developments/Updates
• 7.3 Bio-Tech Pharmacal
  • 7.3.1 Bio-Tech Pharmacal Bio-based Pentylenediamine Corporation Information
  • 7.3.2 Bio-Tech Pharmacal Bio-based Pentylenediamine Product Portfolio
  • 7.3.3 Bio-Tech Pharmacal Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.3.4 Bio-Tech Pharmacal Main Business and Markets Served
  • 7.3.5 Bio-Tech Pharmacal Recent Developments/Updates
• 7.4 Goodwin Biotechnology
  • 7.4.1 Goodwin Biotechnology Bio-based Pentylenediamine Corporation Information
  • 7.4.2 Goodwin Biotechnology Bio-based Pentylenediamine Product Portfolio
  • 7.4.3 Goodwin Biotechnology Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.4.4 Goodwin Biotechnology Main Business and Markets Served
  • 7.4.5 Goodwin Biotechnology Recent Developments/Updates
• 7.5 Xenon Pharmaceuticals
  • 7.5.1 Xenon Pharmaceuticals Bio-based Pentylenediamine Corporation Information
  • 7.5.2 Xenon Pharmaceuticals Bio-based Pentylenediamine Product Portfolio
  • 7.5.3 Xenon Pharmaceuticals Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.5.4 Xenon Pharmaceuticals Main Business and Markets Served
  • 7.5.5 Xenon Pharmaceuticals Recent Developments/Updates
• 7.6 Nektar Therapeutics
  • 7.6.1 Nektar Therapeutics Bio-based Pentylenediamine Corporation Information
  • 7.6.2 Nektar Therapeutics Bio-based Pentylenediamine Product Portfolio
  • 7.6.3 Nektar Therapeutics Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.6.4 Nektar Therapeutics Main Business and Markets Served
  • 7.6.5 Nektar Therapeutics Recent Developments/Updates
• 7.7 Midas Pharmaceuticals
  • 7.7.1 Midas Pharmaceuticals Bio-based Pentylenediamine Corporation Information
  • 7.7.2 Midas Pharmaceuticals Bio-based Pentylenediamine Product Portfolio
  • 7.7.3 Midas Pharmaceuticals Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.7.4 Midas Pharmaceuticals Main Business and Markets Served
  • 7.7.5 Midas Pharmaceuticals Recent Developments/Updates
• 7.8 Kedrion Biopharma
  • 7.8.1 Kedrion Biopharma Bio-based Pentylenediamine Corporation Information
  • 7.8.2 Kedrion Biopharma Bio-based Pentylenediamine Product Portfolio
  • 7.8.3 Kedrion Biopharma Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.8.4 Kedrion Biopharma Main Business and Markets Served
  • 7.7.5 Kedrion Biopharma Recent Developments/Updates
• 7.9 Xcelthera
  • 7.9.1 Xcelthera Bio-based Pentylenediamine Corporation Information
  • 7.9.2 Xcelthera Bio-based Pentylenediamine Product Portfolio
  • 7.9.3 Xcelthera Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.9.4 Xcelthera Main Business and Markets Served
  • 7.9.5 Xcelthera Recent Developments/Updates
• 7.10 Anichem
  • 7.10.1 Anichem Bio-based Pentylenediamine Corporation Information
  • 7.10.2 Anichem Bio-based Pentylenediamine Product Portfolio
  • 7.10.3 Anichem Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.10.4 Anichem Main Business and Markets Served
  • 7.10.5 Anichem Recent Developments/Updates
• 7.11 ALC Bio Innovations
  • 7.11.1 ALC Bio Innovations Bio-based Pentylenediamine Corporation Information
  • 7.11.2 ALC Bio Innovations Bio-based Pentylenediamine Product Portfolio
  • 7.11.3 ALC Bio Innovations Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.11.4 ALC Bio Innovations Main Business and Markets Served
  • 7.11.5 ALC Bio Innovations Recent Developments/Updates
• 7.12 ACADIA Pharmaceuticals
  • 7.12.1 ACADIA Pharmaceuticals Bio-based Pentylenediamine Corporation Information
  • 7.12.2 ACADIA Pharmaceuticals Bio-based Pentylenediamine Product Portfolio
  • 7.12.3 ACADIA Pharmaceuticals Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.12.4 ACADIA Pharmaceuticals Main Business and Markets Served
  • 7.12.5 ACADIA Pharmaceuticals Recent Developments/Updates
• 7.13 AbbVie Inc.
  • 7.13.1 AbbVie Inc. Bio-based Pentylenediamine Corporation Information
  • 7.13.2 AbbVie Inc. Bio-based Pentylenediamine Product Portfolio
  • 7.13.3 AbbVie Inc. Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.13.4 AbbVie Inc. Main Business and Markets Served
  • 7.13.5 AbbVie Inc. Recent Developments/Updates
• 7.14 Ology Bioservices
  • 7.14.1 Ology Bioservices Bio-based Pentylenediamine Corporation Information
  • 7.14.2 Ology Bioservices Bio-based Pentylenediamine Product Portfolio
  • 7.14.3 Ology Bioservices Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.14.4 Ology Bioservices Main Business and Markets Served
  • 7.14.5 Ology Bioservices Recent Developments/Updates
• 7.15 QMI - Quality Management
  • 7.15.1 QMI - Quality Management Bio-based Pentylenediamine Corporation Information
  • 7.15.2 QMI - Quality Management Bio-based Pentylenediamine Product Portfolio
  • 7.15.3 QMI - Quality Management Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.15.4 QMI - Quality Management Main Business and Markets Served
  • 7.15.5 QMI - Quality Management Recent Developments/Updates
• 7.16 Biomiga
  • 7.16.1 Biomiga Bio-based Pentylenediamine Corporation Information
  • 7.16.2 Biomiga Bio-based Pentylenediamine Product Portfolio
  • 7.16.3 Biomiga Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.16.4 Biomiga Main Business and Markets Served
  • 7.16.5 Biomiga Recent Developments/Updates
• 7.17 Molecular Targeting Technologies
  • 7.17.1 Molecular Targeting Technologies Bio-based Pentylenediamine Corporation Information
  • 7.17.2 Molecular Targeting Technologies Bio-based Pentylenediamine Product Portfolio
  • 7.17.3 Molecular Targeting Technologies Bio-based Pentylenediamine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.17.4 Molecular Targeting Technologies Main Business and Markets Served
  • 7.17.5 Molecular Targeting Technologies Recent Developments/Updates

8 Bio-based Pentylenediamine Manufacturing Cost Analysis

• 8.1 Bio-based Pentylenediamine Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Key Raw Materials Price Trend
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Bio-based Pentylenediamine
• 8.4 Bio-based Pentylenediamine Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
• 9.2 Bio-based Pentylenediamine Distributors List
• 9.3 Bio-based Pentylenediamine Customers

10 Market Dynamics

• 10.1 Bio-based Pentylenediamine Industry Trends
• 10.2 Bio-based Pentylenediamine Growth Drivers
• 10.3 Bio-based Pentylenediamine Market Challenges
• 10.4 Bio-based Pentylenediamine Market Restraints

11 Production and Supply Forecast

• 11.1 Global Forecasted Production of Bio-based Pentylenediamine by Region (2022-2027)
• 11.2 North America Bio-based Pentylenediamine Production, Revenue Forecast (2022-2027)
• 11.3 Europe Bio-based Pentylenediamine Production, Revenue Forecast (2022-2027)
• 11.4 China Bio-based Pentylenediamine Production, Revenue Forecast (2022-2027)
• 11.5 Japan Bio-based Pentylenediamine Production, Revenue Forecast (2022-2027)

12 Consumption and Demand Forecast

• 12.1 Global Forecasted Demand Analysis of Bio-based Pentylenediamine
• 12.2 North America Forecasted Consumption of Bio-based Pentylenediamine by Country
• 12.3 Europe Market Forecasted Consumption of Bio-based Pentylenediamine by Country
• 12.4 Asia Pacific Market Forecasted Consumption of Bio-based Pentylenediamine by Region
• 12.5 Latin America Forecasted Consumption of Bio-based Pentylenediamine by Country

13 Forecast by Type and by Application (2022-2027)

• 13.1 Global Production, Revenue and Price Forecast by Type (2022-2027)
  • 13.1.1 Global Forecasted Production of Bio-based Pentylenediamine by Type (2022-2027)
  • 13.1.2 Global Forecasted Revenue of Bio-based Pentylenediamine by Type (2022-2027)
  • 13.1.3 Global Forecasted Price of Bio-based Pentylenediamine by Type (2022-2027)
• 13.2 Global Forecasted Consumption of Bio-based Pentylenediamine by Application (2022-2027)

14 Research Finding and Conclusion

15 Methodology and Data Source

• 15.1 Methodology/Research Approach
  • 15.1.1 Research Programs/Design
  • 15.1.2 Market Size Estimation
  • 15.1.3 Market Breakdown and Data Triangulation
• 15.2 Data Source
  • 15.2.1 Secondary Sources
  • 15.2.2 Primary Sources
• 15.3 Author List